Glaukos Price to Free Cash Flow Ratio 2014-2024 | GKOS
Historical price to free cash flow ratio values for Glaukos (GKOS) since 2014.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Glaukos Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2024-11-18 | 136.98 | 0.00 | |
| 2024-09-30 | 130.28 | $-1.52 | 0.00 |
| 2024-06-30 | 118.35 | $-1.63 | 0.00 |
| 2024-03-31 | 94.29 | $-1.53 | 0.00 |
| 2023-12-31 | 79.49 | $-1.61 | 0.00 |
| 2023-09-30 | 75.25 | $-1.56 | 0.00 |
| 2023-06-30 | 71.21 | $-2.01 | 0.00 |
| 2023-03-31 | 50.10 | $-2.18 | 0.00 |
| 2022-12-31 | 43.68 | $-1.33 | 0.00 |
| 2022-09-30 | 53.24 | $-1.38 | 0.00 |
| 2022-06-30 | 45.42 | $-0.52 | 0.00 |
| 2022-03-31 | 57.82 | $-0.15 | 0.00 |
| 2021-12-31 | 44.44 | $-0.50 | 0.00 |
| 2021-09-30 | 48.17 | $0.00 | 0.00 |
| 2021-06-30 | 84.83 | $-0.42 | 0.00 |
| 2021-03-31 | 83.93 | $-0.64 | 0.00 |
| 2020-12-31 | 75.26 | $-0.67 | 0.00 |
| 2020-09-30 | 49.52 | $-0.99 | 0.00 |
| 2020-06-30 | 38.42 | $-0.86 | 0.00 |
| 2020-03-31 | 30.86 | $-0.43 | 0.00 |
| 2019-12-31 | 54.47 | $-0.12 | 0.00 |
| 2019-09-30 | 62.51 | $0.28 | 224.78 |
| 2019-06-30 | 75.40 | $0.49 | 153.19 |
| 2019-03-31 | 78.37 | $0.45 | 173.42 |
| 2018-12-31 | 56.17 | $0.24 | 232.01 |
| 2018-09-30 | 64.90 | $0.30 | 213.84 |
| 2018-06-30 | 40.64 | $0.31 | 131.27 |
| 2018-03-31 | 30.83 | $0.31 | 98.88 |
| 2017-12-31 | 25.65 | $0.58 | 44.59 |
| 2017-09-30 | 33.00 | $0.28 | 118.03 |
| 2017-06-30 | 41.47 | $0.19 | 216.89 |
| 2017-03-31 | 51.30 | $0.24 | 210.50 |
| 2016-12-31 | 34.30 | $0.17 | 207.38 |
| 2016-09-30 | 37.74 | $0.02 | 1859.11 |
| 2016-06-30 | 29.16 | $0.41 | 71.86 |
| 2016-03-31 | 16.86 | $-0.21 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $7.553B | $0.315B |
| Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $191.744B | 23.39 |
| Intuitive Surgical (ISRG) | United States | $189.359B | 99.00 |
| Alcon (ALC) | Switzerland | $42.325B | 28.32 |
| Edwards Lifesciences (EW) | United States | $41.221B | 26.18 |
| IQVIA Holdings (IQV) | United States | $34.674B | 19.10 |
| IDEXX Laboratories (IDXX) | United States | $34.378B | 40.49 |
| DexCom (DXCM) | United States | $29.791B | 44.87 |
| STERIS (STE) | Ireland | $21.428B | 24.67 |
| SONOVA HOLDING (SONVY) | Switzerland | $21.334B | 0.00 |
| Waters (WAT) | United States | $21.106B | 31.21 |
| Hologic (HOLX) | United States | $18.301B | 19.31 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.981B | 13.32 |
| Sysmex ADR (SSMXY) | Japan | $12.562B | 39.39 |
| Globus Medical (GMED) | United States | $11.143B | 28.22 |
| Penumbra (PEN) | United States | $9.229B | 90.41 |
| Teleflex (TFX) | United States | $9.030B | 14.40 |
| Masimo (MASI) | United States | $8.611B | 41.67 |
| PROCEPT BioRobotics (PRCT) | United States | $4.748B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.512B | 25.58 |
| Inari Medical (NARI) | United States | $3.004B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.852B | 16.47 |
| Veracyte (VCYT) | United States | $2.845B | 85.37 |
| TransMedics (TMDX) | United States | $2.716B | 86.10 |
| Nihon Kohden (NHNKY) | Japan | $2.378B | 18.07 |
| Elekta AB (EKTAY) | Sweden | $2.194B | 17.88 |
| Tandem Diabetes Care (TNDM) | United States | $1.889B | 0.00 |
| RxSight (RXST) | United States | $1.800B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.735B | 9.07 |
| Alphatec Holdings (ATEC) | United States | $1.208B | 0.00 |
| OPKO Health (OPK) | United States | $1.119B | 0.00 |
| Artivion (AORT) | United States | $1.118B | 74.08 |
| Pulse Biosciences (PLSE) | United States | $1.014B | 0.00 |
| Paragon 28 (FNA) | United States | $0.854B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.833B | 14.16 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.699B | 0.00 |
| IRadimed (IRMD) | United States | $0.647B | 34.97 |
| AxoGen (AXGN) | United States | $0.563B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.560B | 13.19 |
| OrthoPediatrics (KIDS) | United States | $0.552B | 0.00 |
| SiBone (SIBN) | United States | $0.518B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.459B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.430B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.379B | 20.49 |
| Semler Scientific (SMLR) | United States | $0.343B | 23.03 |
| CVRx (CVRX) | United States | $0.331B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.311B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.296B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.280B | 0.00 |
| NeuroPace (NPCE) | United States | $0.267B | 0.00 |
| Inogen (INGN) | United States | $0.227B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.190B | 0.00 |
| Accuray (ARAY) | United States | $0.171B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.161B | 0.00 |
| Nevro (NVRO) | United States | $0.161B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.160B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.144B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.138B | 14.75 |
| Spectral Diagnostics (EDTXF) | Canada | $0.112B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.088B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.086B | 0.00 |
| LENSAR (LNSR) | United States | $0.084B | 0.00 |
| 908 Devices (MASS) | United States | $0.082B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.079B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.068B | 0.00 |
| InspireMD (NSPR) | Israel | $0.068B | 0.00 |
| Hyperfine (HYPR) | United States | $0.061B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.058B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.056B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.055B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.046B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.045B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.040B | 0.00 |
| Envoy Medical (COCH) | United States | $0.039B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.027B | 0.00 |
| Spectral AI (MDAI) | United States | $0.026B | 0.00 |
| Neuronetics (STIM) | United States | $0.024B | 0.00 |
| NexGel (NXGL) | United States | $0.021B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.016B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.016B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.015B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.014B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.011B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.011B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.009B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |